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Extrachromosomal Probes for Mutagenesis
by Carcinogens: Studies on the Mutagenic
Activity of 06-Methylguanine Built into a
Unique Site in a Viral Genome
by John M. Essigmann,* Kerry W. Fowler,*t Calvert L.
Green,* and Edward L. Loechler*§
This work examines the mutagenic activity of06-methylguanine (O6MeGua), a DNA adduct formed by
certain carcinogenic alkylatingagents. Atetranucleotide, 5'-HOTpm6GpCpA-3', was synthesized and ligated
into afour-base gap in the unique Pst I site ofthe duplex genome oftheE. colivirus, M13mp8. The double-
stranded ligation product was converted to single-stranded form and used to transform E. coli to produce
progeny phage. The mutation frequency of06MeGua was defined as the percentage ofprogeny phage with
mutations in their Pst I site, and this value was determined to be 0.4%. To determine the impact of DNA
repair on mutagenesis, cellular levels of 06MeGua-DNA methyltransferase (an 06MeGua-repair protein)
were depleted by treatment of host cells for virus replication with N-methyl-N'-nitro-N-nitrosoguanidine
(MNNG) prior to viral DNA uptake. In these host cells, the mutation frequency due to O6MeGua increased
markedly with increasing MNNG dose (the highest mutation frequency observed was 20%). DNA sequence
analysis of mutant genomes revealed that in both MNNG treated and untreated cells, O6MeGua induced
exclusively G to A transitions.
Introduction
Chemical and physical agents induce cancer by mech-
anisms that have only recently begun to be understood.
The current view is that carcinogenic agents damage
DNA, forming lesions that subsequently are acted upon
by constitutive orinducible enzymatic systems to create
mutations. These mutations could initiate carcinogen-
esis ifthey either cause, or create a favorable environ-
ment for the further genetic or nongenetic changes
required for full development of the transformed
phenotype.
Several independent lines of investigation have pro-
vided the rationale for suggesting a mutational origin
for cancer. First, a strong empirical relationship exists
between the mutagenic and carcinogenic effects of
chemicals (1), with positive mutagenic activity being
demonstrated for 80 to 90% of the carcinogens tested
(2). Second, it has been observed that people with a
genetic defect in one ofthe steps of DNA repair are at
veryhigh risk to certain forms ofcancer (3); presumably
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the inability of a cell to remove premutagenic lesions
from DNA increases its likelihood ofbecoming the pro-
genitoroftumorcellpopulation. Finally, much has been
discovered recently as to the identities of some of the
genes apparently involved in the origins ofsome human
and animal cancers (4,5). These studies have shown that
some oncogenes appearto be variants ofnormal cellular
genesthatarelikelytohaveundergonemutation. Taken
together, all ofthe evidence cited above presents agood
case in support of somatic mutations being responsible
for at least some cancers.
In view ofthe relatively firm relationship that exists
between DNA modification and mutagenesis, and the
further, albeit more tentative association between mu-
tagenesis and carcinogenesis, it has become ofinterest
to elucidate the specificmechanisms bywhich mutations
are induced by the DNA lesions caused by chemical
carcinogens. One factor that greatly complicates this
analysis derives from the observation that the DNA-
damaging forms of carcinogens generally create a wide
variety of structurally different lesions within the gen-
ome (6-10). Multiple DNA-bound forms ofcarcinogens,
herein referred to as adducts, result in part because the
pathways of carcinogen activation often generate sev-
eral chemically distinct reactive species (6). In addition,
the presumed relevant target for these species, DNA,ESSIGMANN ET AL.
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FIGURE 1. Structure ofthe chemically synthesized tetranucleotide,
5'-d(Tpm6G CpA)-3'.
is not a simple reactant, but a composite made up ofat
least 20 reactive centers that differ not only as to their
inherent chemical reactivity but also as to their steric
accessibility to activated carcinogens. Understandably,
the result of carcinogen-DNA interactions usually is a
structurally heterogeneous array of DNA adducts.
Moreover, as a further complicating factor, this profile
often varies markedly over time because some DNA
adducts are removed rapidly whereas others are re-
moved slowly if at all.
The multiplicity ofDNA adducts created bythe bind-
ing ofcarcinogens to DNA and the fact that the adduct
proffle changes over time make it difficult to define the
relationship between the chemical structure of an in-
dividual adduct and its biological effects. The approach
our laboratory has taken for establishing such relation-
ships is to situate individual adducts at defined sites in
genomes, allow enzymatic processing to occur in vivo,
and then assess the genetic effects of the adduct by
measuring the amount and type of DNA sequence al-
teration(s) induced at or in the vicinity ofthe site orig-
inally occupied by the adduct.
The prototype we chose for these studies is 06-meth-
ylguanine (0 MeGua), which is one ofthe DNA adducts
formed by certain carcinogenic alkylating agents. This
lesion was chosen for several reasons. First, the pres-
ence and persistence of the 06-alkylguanines correlate
well with the mutagenic and carcinogenic effects of al-
kylating agents (11-13). Second, the reaction of alkyl-
ating agents with the 06-atom ofguanine fixes the enol
tautomer of this base, in which guanine has been pre-
dicted tobase-pairwiththymine aswellascytosine (14).
Muchdatafrominvitro systems supportthis prediction
(15-18). Third, as demonstrated below, the chemical
properties ofthis base made it an acceptable substrate
for chemical synthesis of DNA. Finally, it was antici-
patedthatthisadductwould cause onlyminordistortion
of DNA structure, and thus it could be built into DNA
in high yield by using recombinant DNA techniques.
Chemical Synthesis of an
Oligonucleotide Containing
06-Methylguanine
Forreasons made clearin the next section, it was our
objective to build O6MeGua into DNA as part of the
tetranucleotide, 5'-d(Tpm6GpCpA)-3' (Fig. 1) (19). Ini-
tially, 06-methyldeoxyguanosine was prepared by the
condensation of 2-amino-6-chloropurine with 2-deoxy-
3,5,0-p-toluoyl-D-erythropentosyl chloride, followed by
N-acylation, fractional crystallization of the 0-anomer,
and methanolysis. Subsequent reactions yielded the O6-
methyldeoxyguanosine residue protected at the 5'-hy-
droxyl by a dimethoxytrityl group and at the 3'-hy-
droxyl by a p-chlorophenylcyanoethyl phosphotriester
moiety. The strategy for assimilating this 3',5'-pro-
tected adduct into an oligonucleotide was initially to
prepare two dimers, fully protected derivatives of
5'-TPm6G-3' and 5'-CpA-3'. The 3' and 5' ends of the
first and second dimers, respectively, were deprotected
and condensed using mesitylenesulfonyl tetrazolide,
yielding a protected tetranucleotide. Removal of the
protecting groups produced the adduct-containing te-
tranucleotide, 5'-T m6G C A-3' (Fig. 1), which was
structurally identified by its mass and NMR spectra,
and by chemical composition and sequence studies.
Site-Specific Incorporation of 06_
Methylguanine into a Viral Genome
The DNA vector chosen for the biological aspect of
these studies was the E. coli virus, M13mp8. This virus
was chosen because its DNA sequence is known (20)
and the biology ofits replication is wellunderstood (21),
because itisrelatively easytoproducethe DNAneeded
for manipulation using recombinant DNA techniques,
and because its DNA replication mechanism provides
the option ofconstructing either single-stranded (ss) or
double-stranded (ds) adduct-containing genomes.
In order to build the adduct-containing tetranucleo-
tide into M13mp8, initially it was our objective to re-
move a 5'-TpGpCpA-3'segment from the circular duplex
genome; these four bases are located within the unique
recognition site for the restriction endonuclease, Pst I.
The first step in this procedure (22) was to treat the
replicative form (RF) of M13mp8 with Pst I (Fig. 2).
This produced a linear DNA molecule with 3'-over-
hangingends, which subsequently wereremovedbythe
3'-exonuclease activity of T4 DNA polymerase. The
product was a blunt-ended linear genome 7225 base pairs
(bp) in length, i.e., the length ofthe genome minus four
bp. Themissingfournucleotideswereoriginallypresent
in the center of the Pst I recognition sequence
(5'CTGCAG3').
A circular DNA structure containing a four-nucleo-
tide gap was created by forming a heteroduplex be-
tween the aforementioned DNA molecule (from which
the TGCA sequence had been deleted) and a second
linear DNA molecule that had an intact Pst I site. The
heteroduplex was formed by combiningthe linearprod-
uctoftheblunt-endingreactionwithM13mp8DNAthat
previously had been linearized with Bgl II; heat dena-
turation followed by controlled cooling of the mixture
resulted in approximately equal amounts ofthe original
linear structures (not shown as products in Fig. 2A) and
circular heteroduplexes. In these heteroduplexes there
was an exactly positioned four-nucleotide gap in the
strand originally treated with Pst I and then blunt-
ended. The intact DNA strand opposite the gap had the
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FIGURE 2. Site-specific insertion of O6MeGua into the unique Pst I
recognition site of M13mp&. Procedural details are given in the
text. CIP is calf intestinal alkaline phosphatase.
sequence 3'-ApCpGpTp-5' and thus displayed partial
complementarity to the chemically synthesized 5'-
Tpm GpCpA-3' molecule described above.
The 5'-terminal deoxythymidine of the synthetic te-
tranucleotide was phosphorylated by using T4 polynu-
cleotide kinase and [-y- P]ATP (Fig. 2B) prior to the
ligation step. As judged by HPLC analysis of the re-
action mixture, 97% phosphorylation was achieved. The
high specific activity of 5'-[32P]-Tpm6G C A-3' (approx-
imately 109 dpm4l,g) provided a means for measuring
the yield ofthe ligation step. In the presence ofT4 DNA
ligase and a 2000-fold molar excess of 5'- Tpm6G C A-
3', the yield of ligation into gapped duplex DNA was
approximately 50%. This high yield indicated that the
tetramer, when present inlarge excess, was sufficiently
complementary to the ligation target for DNA ligase to
very effectively form phosphodiester bonds. Electro-
phoresis followed by autoradiography of the ligation
mixture revealed that incorporation of [32p] occurred
principally in the circular heteroduplexes (22).
The heteroduplex DNA structures that received the
modified oligonucleotide had gaps that formed with equal
probability in either ofthe two complementary strands
(Fig. 2A). Thus, ligation occurred into these gaps in
either of two possible orientations, resulting in place-
ment of O6MeGua at position 6255 when it was ligated
into the (+) strand and at position 6256 when it was
introduced intothe (-) strand (Fig. 2B). It isnoteworthy
that the DNA strand opposite the gaps had a nick in
the Bgl II recognition site. This nick resulted from an
optional step in which M13mp8 linearized with Bgl II
was treated with calf intestinal alkaline phosphatase
(CIP) prior to heteroduplex formation. This treatment
removed the 5'-terminal phosphate residues and made
it impossible for DNA ligase to seal the nick at the Bgl
II site in the circular heteroduplex shown in Figure 2A.
The existence ofthis nick provided a means for remov-
ing the strand complementary to the one containing the
adduct, thereby creating single-stranded (ss) adduct-
containing genomes.
The adduct-containing genomes shown as ligation
products at the bottom of Figure 2B were subjected to
a series of characterization experiments (22). One of
these experiments established that both ends of the
modified tetranucleotide had ligated into the gap orig-
inally present in the duplex genome; it was important
that this step went to completion since failure of one of
the ends to ligate would have left a nick in the DNA
molecule near the adduct, and such a nick could have
provided a mechanism for the efficient repair of the
adducted genome upon its entry into cells. The position
ofthe adduct was localized to the Pst I site ofM13mp8
by the following experiments. After digestion of the
modified genome with a restriction endonuclease with
multiple recognition sites in M13mp8, it was found that
the 32P-label from the 5'-end ofthe tetranucleotide was
present exclusively within the restriction fragment that
contained the Pst I site. It was also demonstrated that
the presence of O6MeGua in the Pst I site inhibited the
ability ofthe Pst I endonuclease to cleave DNA. How-
ever, sensitivity to Pst I cleavage could be restored if
the DNA was treated, prior to Pst I treatment, with a
purified repair protein that specifically removed the O6-
mehyl group from guanine. Collectively, the data on
characterization of the adduct-containing genome indi-
cated that 06-MeGua was located with good yield and
purity at the predicted site in the M13mp8 genome.
Mutation Frequency of
06-Methylguanine in Vivo
As indicated above, ds genomes were constructed that
contained a single O6MeGua residue within the unique
Pst I site of M13mp8. There was a nick situated in the
strand opposite that containing the adduct (Fig. 2B),
and thus alkali denaturation yielded single-stranded
monoadducted genomes (Fig. 3). It was desirable to
have the option to remove the complementary strand,
because it has been reported that the major repair pro-
tein for O6MeGua is less active on ss DNA than on
double-stranded (ds) substrates (23).
To investigate mutagenesis by O6MeGua, ss O6MeGua-
M13mp8 was introduced into E. coli MM294A cells,
where the phage genomes were acted upon by the en-
dogenous replication and repair systems (Fig. 3) (24).
Amixture ofwild type and mutantphage was produced,
which was used to produce the ds replicative form (RF)
DNA. Themethodused todifferentiate mutant and wild
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FIGURE 3. Isolation of O6MeGua-derived mutants. ds O6MeGua-
M13mp8 was base-denatured to give ss O6MeGua-Ml3mp8 (step
1), which then was used to transform E. coli MM294A cells (step
2). A mixture of wild type and mutant phage was produced (X
denotes position of mutation) and used to infect E. coli JM103
cells. RF DNA prepared from these phage (step 3) was treated
with Pst I (step 4); mutant DNA remained circular, whereas wild
type molecules were linearized and subsequently selectively de-
graded with exonuclease III (step 5). Steps 4 and 5 were repeated,
and the remaining DNA (an essentially pure mutant population)
was retransfected intoJM103 cells to produce phage (step 6). The
ss phage genome was isolated for DNA sequencing (steps 7-9).
type phage was based on the fact that the progenitor
phage DNA molecule (step 1 of Fig. 3) contained the
adduct in the unique Pst I recognition site. Mutations
affecting this site rendered the RF DNA insensitive to
cleavage by this endonuclease. This property made it
possible to isolate a pure mutant phage population for
DNA sequencing and for calculation of mutation
frequencies.
The mutation frequency of O6MeGua was expressed
as the fraction ofphage produced after step 2 ofFigure
3 with mutations in the Pst I site (24). As indicated by
the DNA sequencing results (see below), the mutations
induced by O6MeGua were at either oftwo guanines in
this site, because as indicated in the previous section
O6MeGua-Ml3mp8 was an equal mixture of genomes
with the single adduct located either in the (+) strand
(position 6255) or in the (-) strand (position 6256) (Fig.
Table 1. Mutation frequency (%) due to
O6MeGua in O6MeGua-Ml3mp8.
MNNG O6MeGua-Ml3mp8
challenge, M13mp8,
p.g/mLa MF-b MF+b MFtb MFe
0 0.08 0.36 0.4 0.03
17 1.3 4.1 5.4 0.11
33 3.6 4.7 8.3 0.20
50 4.1 13.7 17.8 0.16
aSome host cells forO6MeGua-M13mp8 replication were challenged
with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) prior to DNA
uptake; details are given in the text.
bMF+ and MF are the percentage ofprogeny phage with O6MeGua-
derived mutations that originated in the (+) and (-) strands, re-
spectively; the sum of these quantities is MFt.
cThe upper limit ofthe mutation frequency ofa control, which was
the (+) strand ofM13mp8 (this DNA did not contain O6MeGua at the
Pst I site).
2B). As shown in Table 1, the mutation frequencies of
the adduct at these sites (MF + and MF-, respectively)
were determined to be 0.36 and 0.08%, respectively. In
calculating these values it was assumed that an adduct
at a given site gave rise to a mutation at that site; i.e.,
ss O6MeGua-M13mp8 with the adduct in the (+) strand
gave rise tothe mutation observed atposition 6255. The
sum of the values for the mutation frequencies in the
individual strands is defined as the total mutation fre-
quency of O6MeGua, MFt, which was determined to be
approximately 0.4%.
Role of DNA Repair in Protecting
against 06-Methylguanine
Mutagenesis
Others have investigated the miscoding characteris-
tics of O6MeGua in vitro in experiments that typically
have involved random incorporation of O6-substituted
guanines into DNA or RNA polymers, which then were
copied with polymerases (15-17). Subsequently, the
replication products were analyzed for the presence of
noncomplementary nucleotides. The results ofthese ex-
periments have demonstrated that DNA and RNA po-
lymerases misreplicate 06-alkylguanines approximately
one-third ofthe time. Although less workhasbeen done
to estimate themutationfrequencyinvivo, thefewdata
that are available indicate a similar (25) or slightly higher
(26) mutation frequency as compared to that observed
in vitro. There must, however, be an element of un-
certainty as to the accuracy ofthese in vivo estimates,
because the experiments were done with DNAs con-
taining the full range of adducts created by treatment
with alkylating agents.
The mutation frequency we observed in vivo is sev-
eral orders of magnitude less than that determined or
predicted by the experiments cited above. The most
likely reason for this apparent discrepancy is the fact
that in our studies a single adduct was built into the
genome, and this single lesion probably was removed
quickly in E. coli by repair proteins associated with the
adaptive response, specifically, the O6MeGua DNA-
methyltransferase (MT). This protein acts by transfer-
ing the methyl group from 06MeGua in DNA to itself
(27); the alkylated protein is not thought to turn over,
and thus it is irreversibly inactivated in the process of
dealkylating the genome.
We tookadvantage ofthe suicidal property ofthe MT
to diminish the intracellular capacity to repair 06MeGua.
At2minbeforetheO6MeGua-M13mp8uptakestep(step
2 ofFig. 3), host cells were treated with N-methyl-N'-
nitro-N-nitrosoguanidine (MNNG), which introduced
O6MeGua residues into the host chromosome (13). Re-
pair of these lesions depleted endogenous levels of the
MT and thus diminished the ability ofcells to repairthe
single adduct in O6MeGua-M13mp8. MNNG is known
to induce several DNArepair systems, but we estimate
that fixation of O6MeGua as a mutation would occur
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FIGURE 4. DNA sequences ofO6MeGua-induced mutants. DNA ofmutant phage was isolated and sequenced by the method ofSanger. Shown
here are autoradiograms of sequencing gels in the region ofthe M13mp8 genome containing the Pst I sites of (from left to right) (-) strand
mutant, wild type, and (+) strand mutant genomes.
before their induction, and thus the effect of these in-
ducible systems onmutagenesis shouldbe minimal. (We
assumethatO6MeGua-M13mp8isreplicated atthe same
rate as similar ss viruses, and thus it is estimated that
the replication apparatus will encounter the adducted
site within 2 min).
Table 1 presentstheresults ofanexperiment inwhich
the mutation frequency ofO6MeGua was examined in a
series ofcell populations that had been pretreated with
a range ofincreasing doses of MNNG, i.e., treatments
that created a range of reduced MT activities within
the host cells. As expected the mutant fraction derived
from O6MeGua-Ml3mp8 increased with the level of
MNNG treatment. As a control to the above experi-
ment, E. coli cells challenged identically with MNNG
were transformed with wild type M13mp8 DNA. Mu-
tation of this DNA to Pst I insensitivity was insignifi-
cant (Table 1), and this ensured that the observed
mutations did not arise from alkylation of the vector
during MNNG challenge.
Atthe highest level ofMNNG treatment (50 ,ug/mL),
the total MF (MF3) had increased to almost 50times the
comparable value in unchallenged cells. The mutation
frequency ofthis sample (approximately 20%) does not
necessarily represent the inherent mutation efficiency
ofO6MeGua, because the function relating MNNG dose
and mutagenesis (Table 1) was still ascending at this
level ofMNNG challenge; rather, this value represents
the lower limit of the true mutation frequency of this
lesion. Interestingly, at its present value this mutation
frequency is at the lower end ofthe range measured for
mutagenesis of 06-alkyl guanines in vitro (15-17), and
it is within afactoroftwo orthree ofthe level predicted
by indirect in vivo measurements (25,26).
Nature of Mutations Induced by
06-Methylguanine
After the mutant isolation procedure was completed
(i.e., after step 6 ofFig. 3) and individual mutant plaques
were obtained, thesemutantspecieswerecharacterized
by DNA sequencing. In addition to the two O6MeGua-
induced mutant species indicated below, DNA sequenc-
ingrevealed two othermutationalchanges. Specifically,
two types of deletion mutant were induced (four-base,
and approximately 30 base deletions); these appear to
have originated from the genetic engineering tech-
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niques used inthe construction ofthe adducted genome,
and not from mutagenic processing of O6MeGua (24).
These mutant species were readily distinguishable from
O6MeGua-induced mutants.
Figure 4 contains an autoradiogram of a DNA se-
quencinggel andreveals the DNAsequences ofthe wild
type and of the two O6MeGua-induced mutant species
in the vicinity of the Pst I site of M13mp8. The only
sequence change in the left-most lanes was a G to A
transition at position 6256. We assume this was due to
misreplication of the ss 06MeGua-Ml3mp8 genome in
which the adduct was located in the (-) strand (see Fig.
2B). Presumably, 06MeGua base-paired with thymine
during synthesis of(+) strand in vivo, creating aphage
population with T rather than C opposite the original
position of the lesion. The rightmost lanes show the
sequence of the mutant we assume issued from the
O6MeGua-Ml3mp8 genome in which the adduct was in
the (+) strand. The sequencing data indicate that a C
to T change had occurred at position 6255; since the
sequence ofthe (-) strand appears inthe autoradiogram,
this means that in the complementary (+) strand a G
to A change had occurred. Thus the sequencing data
are consistent with the original prediction based on model
building (14) and invtitro data (cited above) that 06MeGua
would induce G to A transitions. A total of 60 mutants
have been sequenced, and all have shown this base
change.
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